Skip to navigation Skip to content

Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

Posting a Trial

If you would like us to post a study on these pages, please email to find out what information you need to submit for review.


Clinical trials help to determine if treatments are safe and effective. Studies are monitored to ensure that the rights and safety of all participants are protected. Make an informed decision before agreeing to participate. Read more in our Guide to Participating in Clinical Trials.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: Ocrelizumab

    An open-label study to evaluate the effectiveness and safety of ocrelizumab in patients with relapsing remitting multiple sclerosis who have had a sub-optimal response to an adequate course of disease-modifying treatment.
  2. Clinical Trial: Functional Electrical Stimulation Cycling Versus Cycling Only

    People at least 18 years of age with a diagnosis of multiple sclerosis are needed to participate in a cycling study. Individuals must be ambulatory and have transportation. Participation involves eight weeks of training on an exercise bike with or without electrodes stimulatin...
  3. Clinical Trial: Complementary and Alternative Medicine Telerehabilitation Intervention

    The purpose of this study is to compare the effects of two delivery models of an evidence-based complementary alternative medicine (CAM) program that combines neurorehabilitative (functional) exercise, Yoga and Pilates for individuals with multiple sclerosis (MS).  CAM will be...
  4. Clinical Trial: Dysport® (AbobotulinumtoxinA)

    A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor...
  5. Ofatumumab Versus Teriflunomide

    To compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing multiple sclerosis.
  6. Clinical Trial: ALKS 8700

    This study will evaluate the long-term safety and tolerability of oral ALKS 8700 for the treatment of RRMS
  7. Clinical Trial: Transcranial Direct Current Stimulation

    This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities, such as working memory. In this research, a device is used to deliver very weak electrical current to the surface of the scalp while partic...
  8. Clinical Trial: N-Acetyl Cysteine

    The study consists of two arms. The first arm of this study will receive intravenous and oral NAC, a strong antioxidant that increases brain glutathione. NAC, is the N-acetyl derivative of the naturally occurring amino acid, L-cysteine. It has the potential to increase glutath...
  9. Clinical Trial: Tecfidera (Dimethyl Fumarate)

    An observational trial in which patients who are being newly prescribed dimethyl fumarate (Tecfidera) will be asked to follow their use with patient-responded outcome questionnaires.  
  10. Clinical Trial: Ofatumumab versus Teriflunomide

    A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis.


Learn About Clinical Trials

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us
Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here